Home > Healthcare > Medical Devices > Diagnostic Devices > Spirometer Market
Based on product, the devices segment recorded significant revenue share in 2023 and is anticipated to reach over USD 1.4 billion by 2032. This is due to the ongoing technological advancements, including the development of portable and integrated devices. Of late, there have been significant innovations in spirometer devices to enhance usability and connectivity. Additionally, the integration of spirometry devices with electronic health records along with the continuous improvements and increasing adoption rates will fuel the product demand.
Based on technology, the spirometer market is segmented into volume measurement, flow measurement, and peak flow meters. The volume measurement segment is anticipated to reach USD 962.9 billion by 2032, owing to the strong need to accurately diagnose and monitor respiratory ailments, including asthma, COPD, and restrictive lung diseases. Spirometers deployed with volume measured technology are preferred by professional organizations and guidelines, emerging necessary in hospitals, clinics, and diagnostic laboratories for routine respiratory disease testing and evaluation. The rapid advances in spirometry technology leading to the development of more sophisticated and user-friendly volume-based spirometers will drive the market expansion.
Based on application, the spirometer market from the COPD segment may reach USD 964 million by 2032. This is majorly propelled by the rising prevalence of COPD (chronic obstructive pulmonary disease) globally. Continuous advancements in spirometry technology are enabling more accurate diagnosis and monitoring of COPD progression. Healthcare providers increasingly rely on spirometry testing for early detection and personalized treatment strategies. Moreover, the ongoing R&D efforts aimed at enhancing the capabilities in managing COPD and ensuring its continued prominence will favor the segment growth in the coming years.
North America spirometer market size accounted for USD 368.9 million in revenue in 2023 and is predicted to witness 8.9% CAGR through 2032. The growth can be ascribed to the expanding utilization of telehealth services, particularly due to the onset of the COVID-19 pandemic. Spirometry devices are increasingly employed in the region for remote consultations and monitoring. This trend will be fueled by advancements in telehealth technology and the growing acceptance of virtual healthcare solutions. The ongoing telehealth revolution will thus play a key role in the regional industry growth.